Epigenetics in Molecular Epidemiology of Cancer: A New Scope

Advances in Genetics

Volumn 71, Issue C, 2010, Pages 211-235

  Yuasa, Yasuhito ^a  

^a TOKYO MEDICAL AND DENTAL UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

BIOLOGICAL MARKER; HEAVY METAL; ORGANIC COMPOUND;

ANIMAL; ARTICLE; DNA METHYLATION; ENVIRONMENTAL EXPOSURE; FEMALE; GENE EXPRESSION; GENETIC EPIGENESIS; GENETICS; HUMAN; MALE; MOLECULAR EPIDEMIOLOGY; MOUSE; NEOPLASM; RISK FACTOR;

ANIMALS; BIOLOGICAL MARKERS; DNA METHYLATION; ENVIRONMENTAL EXPOSURE; EPIGENESIS, GENETIC; FEMALE; GENE EXPRESSION; HUMANS; MALE; METALS, HEAVY; MICE; MOLECULAR EPIDEMIOLOGY; NEOPLASMS; ORGANIC CHEMICALS; RISK FACTORS;

EID: 77957371318     PISSN: 00652660     EISSN: None     Source Type: Book Series    
DOI: 10.1016/B978-0-12-380864-6.00007-9     Document Type: Book

References (66)

1. Ahuja N., Li Q., Mohan A.L., Baylin S.B., Issa J.P. Aging and DNA methylation in colorectal mucosa and cancer. Cancer Res. 1998, 58:5489-5494.
2. Ally M.S., Al-Ghnaniem R., Pufulete M. The relationship between gene-specific DNA methylation in leukocytes and normal colorectal mucosa in subjects with and without colorectal tumors. Cancer Epidemiol. Biomarkers Prev. 2009, 18:922-928.
3. Anway M.D., Cupp A.S., Uzumcu M., Skinner M.K. Epigenetic transgenerational actions of endocrine disruptors and male fertility. Science 2005, 308:1466-1469.
4. Arasaradnam R.P., Commane D.M., Bradburn D., Mathers J.C. A review of dietary factors and its influence on DNA methylation in colorectal carcinogenesis. Epigenetics 2008, 3:193-198.
5. Azechi H., Nishida N., Fukuda Y., Nishimura T., Minata M., Katsuma H., Kuno M., Ito T., Komeda T., Kita R., et al. Disruption of the p16/cyclin D1/retinoblastoma protein pathway in the majority of human hepatocellular carcinomas. Oncology 2001, 60:346-354.
6. Baccarelli A., Bollati V. Epigenetics and environmental chemicals. Curr. Opin. Pediatr. 2009, 21:243-251.
7. Baek M.J., Piao Z., Kim N.G., Park C., Shin E.C., Park J.H., Jung H.J., Kim C.G., Kim H. p16 is a major inactivation target in hepatocellular carcinoma. Cancer 2000, 89:60-68.
8. Belinsky S.A., Klinge D.M., Liechty K.C., March T.H., Kang T., Gilliland F.D., Sotnic N., Adamova G., Rusinova G., Telnov V. Plutonium targets the p16 gene for inactivation by promoter hypermethylation in human lung adenocarcinoma. Carcinogenesis 2004, 25:1063-1067.
9. Bollati V., Baccarelli A., Hou L., Bonzini M., Fustinoni S., Cavallo D., Byun H.M., Jiang J., Marinelli B., Pesatori A.C., Bertazzi P.A., Yang A.S. Changes in DNA methylation patterns in subjects exposed to low-dose benzene. Cancer Res. 2007, 67:876-880.
10. Chen J.X., Zheng Y., West M., Tang M.S. Carcinogens preferentially bind at methylated CpG in the p53 mutational hot spots. Cancer Res. 1998, 58:2070-2075.
11. Chen H., Liu J., Zhao C.Q., Diwan B.A., Merrick B.A., Waalkes M.P. Association of c-myc overexpression and hyperproliferation with arsenite-induced malignant transformation. Toxicol. Appl. Pharmacol. 2001, 175:260-268.
12. Choi S.W., Stickel F., Baik H.W., Kim Y.I., Seitz H.K., Mason J.B. Chronic alcohol consumption induces genomic but not p53-specific DNA hypomethylation in rat colon. J. Nutr. 1999, 129:1945-1950.
13. Choi J.Y., James S.R., Link P.A., McCann S.E., Hong C.C., Davis W., Nesline M.K., Ambrosone C.B., Karpf A.R. Association between global DNA hypomethylation in leukocytes and risk of breast cancer. Carcinogenesis 2009, 30:1889-1897.
14. Chuang J.C., Yoo C.B., Kwan J.M., Li T.W., Liang G., Yang A.S., Jones P.A. Comparison of biological effects of non-nucleoside DNA methylation inhibitors versus 5-aza-2'-deoxycytidine. Mol. Cancer Ther. 2005, 4:1515-1520.
15. Cui H., Cruz-Correa M., Giardiello F.M., Hutcheon D.F., Kafonek D.R., Brandenburg S., Wu Y., He X., Powe N.R., Feinberg A.P. Loss of IGF2 imprinting: A potential marker of colorectal cancer risk. Science 2003, 299:1753-1755.
16. Day J.K., Bauer A.M., DesBordes C., Zhuang Y., Kim B.E., Newton L.G., Nehram V., Forsee K.M., MacDonald R.S., Besch-Williford C., Huang T.H., Lubahnm D.B. Genistein alters methylation patterns in mice. J. Nutr. Suppl. 2002, 132:2419S-2423S.
17. Dolinoy D.C., Weidmanm J.R., Waterland R.A., Jirtle R.L. Maternal genistein alters coat color and protects Avy mouse offspring from obesity by modifying the fetal epigenome. Environ. Health Perspect. 2006, 114:567-572.
18. Dolinoy D.C., Huang D., Jirtle R.L. Maternal nutrient supplementation counteracts bisphenol A-induced DNA hypomethylation in early development. Proc. Natl. Acad. Sci. USA 2007, 104:13056-13061.
19. Eguchi K., Kanai Y., Kobayashi K., Hirohashi S. DNA hypermethylation at the D17S5 locus in non-small cell lung cancers: Its association with smoking history. Cancer Res. 1997, 57:4913-4915.
20. Fang M.Z., Wang Y., Ai N., Hou Z., Sun Y., Lu H., Welsh W., Yang C.S. Tea polyphenol (-)-epigallocatechin-3-gallate inhibits DNA methyltransferase and reactivates methylation-silenced genes in cancer cell lines. Cancer Res. 2003, 63:7563-7570.
21. Flanagan J.M., Munoz-Alegre M., Henderson S., Tang T., Sun P., Johnson N., Fletcher O., Dos Santos Silva I., Peto J., Boshoff C., et al. Gene-body hypermethylation of ATM in peripheral blood DNA of bilateral breast cancer patients. Hum. Mol. Genet. 2009, 8:1332-1342.
22. Flatley J.E., McNeir K., Balasubramani L., Tidy J., Stuart E.L., Young T.A., Powers H.J. Folate status and aberrant DNA methylation are associated with HPV infection and cervical pathogenesis. Cancer Epidemiol. Biomarkers Prev. 2009, 18:2782-2789.
23. Galvan A., Ioannidis J.P.A., Dragani T.A. Beyond genome-wide association studies: Genetic heterogeneity and individual predisposition to cancer. Trends Genet. 2010, 26:132-141.
24. Ink4a and activation of MAP kinase. Mol. Med. 2002, 8:1-8.
25. Heijmans B.T., Tobi E.W., Stein A.D., Putter H., Blauw G.J., Susser E.S., Slagboom P.E., Lumey L.H. Persistent epigenetic differences associated with prenatal exposure to famine in humans. Proc. Natl. Acad. Sci. USA 2008, 105:17046-17049.
26. Herceg Z. Epigenetics and cancer: Towards an evaluation of the impact of environmental and dietary factors. Mutagenesis 2007, 22:91-103.
27. Hirao T., Bueno R., Chen C.J., Gordon G.J., Heilig E., Kelsey K.T. Alterations of the p16INK4 locus in human malignant mesothelial tumors. Carcinogenesis 2002, 23:1127-1130.
28. Hou L., Wang H., Sartori S., Gawron A., Lissowska J., Bollati V., Tarantini L., Zhang F.F., Zatonski W., Chow W.H., et al. Blood leukocyte DNA hypomethylation and gastric cancer risk in a high-risk Polish population. Int. J. Cancer 2010, DOI: 10.1002/ijc.25190.
29. Hsiung D.T., Marsit C.J., Houseman E.A., Eddy K., Furniss C.S., McClean M.D., Kelsey K.T. Global DNA methylation level in whole blood as a biomarker in head and neck squamous cell carcinoma. Cancer Epidemiol. Biomarkers Prev. 2007, 16:108-114.
30. Hughes L.A., van den Brandt P.A., de Bruïne A.P., Wouters K.A., Hulsmans S., Spiertz A., Goldbohm R.A., de Goeij A.F., Herman J.G., Weijenberg M.P., et al. Early life exposure to famine and colorectal cancer risk: A role for epigenetic mechanisms. PLoS ONE 2009, 4:e7951.
31. Issa J.P., Ottaviano Y.L., Celano P., Hamilton S.R., Davidson N.E., Baylinm S.B. Methylation of the oestrogen receptor CpG island links ageing and neoplasia in human colon. Nat. Genet. 1994, 7:536-540.
32. Ito Y., Koessler T., Ibrahim A.E., Raim S., Vowler S.L., Abu-Amerom S., Silvam A.L., Maia A.T., Huddleston J.E., Uribe-Lewis S., et al. Somatically acquired hypomethylation of IGF2 in breast and colorectal cancer. Hum. Mol. Genet. 2008, 17:2633-2643.
33. Kaaks R., Stattin P., Villar S., Poetsch A.R., Dossusm L., Nieters A., Riboli E., Palmqvist R., Hallmans G., Plass C., et al. Insulin-like growth factor-II methylation status in lymphocyte DNA and colon cancer risk in the Northern Sweden Health and Disease cohort. Cancer Res. 2009, 69:5400-5405.
34. Kang G.H., Lee S., Kim W.H., Lee H.W., Kim J.C., Rhyu M.G., Ro J.Y. Epstein-Barr virus-positive gastric carcinoma demonstrates frequent aberrant methylation of multiple genes and constitutes CpG island methylator phenotype-positive gastric carcinoma. Am. J. Pathol. 2002, 160:787-794.
35. Ke Q., Davidson T., Chen H., Kluz T., Costa M. Alterations of histone modifications and transgene silencing by nickel chloride. Carcinogenesis 2006, 27:1481-1488.
36. Kim D.H., Nelson H.H., Wiencke J.K., Zheng S., Christiani D.C., Wain J.C., Mark E.J., Kelsey K.T. p16INK4a and histology-specific methylation of CpG islands by exposure to tobacco smoke in non-small cell lung cancer. Cancer Res. 2001, 61:3419-3424.
37. Kondo K., Takahashi Y., Hirose Y., Nagao T., Tsuyuguchi M., Hashimoto M., Ochiai A., Monden Y., Tangoku A. The reduced expression and aberrant methylation of p16INK4a in chromate workers with lung cancer. Lung Cancer 2006, 53:295-302.
38. Kusano M., Toyota M., Suzuki H., Akino K., Aoki F., Fujita M., Hosokawa M., Shinomura Y., Imai K., Tokino T. Genetic, epigenetic, and clinicopathologic features of gastric carcinomas with the CpG island methylator phenotype and an association with Epstein-Barr virus. Cancer 2006, 106:1467-1479.
39. Li S., Washburn K.A., Moore R., Uno T., Teng C., Newbold R.R., McLachlan J.A., Negishi M. Developmental exposure to diethylstilbestrol elicits demethylation of estrogen-responsive lactoferrin gene in mouse uterus. Cancer Res. 1997, 57:4356-4359.
40. Lim U., Flood A., Choi S.W., Albanes D., Cross A.J., Schatzkin A., Sinha R., Katki H.A., Cash B., Schoenfeld P., et al. Genomic methylation of leukocyte DNA in relation to colorectal adenoma among asymptomatic women. Gastroenterology 2008, 134:47-55.
41. Maekita T., Nakazawa K., Mihara M., Nakajima T., Yanaoka K., Iguchi M., Arii K., Kaneda A., Tsukamoto T., Tatematsu M., et al. High levels of aberrant DNA methylation in Helicobacter pylori-infected gastric mucosae and its possible association with gastric cancer risk. Clin. Cancer Res. 2006, 12:989-995.
42. "Food, nutrition, physical activity, and the prevention of cancer: A global perspective". 2007, World Cancer Research Fund/American Institute for Cancer Res, Washington, DC. M. Marmot, T. Atinmo, T. Byers, J. Chen, T. Hirohata, A. Jackson, W.P.T. James, L.N. Kolonel, S. Kumanyika, C. Leitzmann (Eds.).
43. Marsit C.J., McClean M.D., Furniss C.S., Kelsey K.T. Epigenetic inactivation of the SFRP genes is associated with drinking, smoking and HPV in head and neck squamous cell carcinoma. Int. J. Cancer 2006, 119:1761-1766.
44. Mays-Hoopes L., Chao W., Butcher H.C., Huang R.C. Decreased methylation of the major mouse long interspersed repeated DNA during aging and in myeloma cells. Dev. Genet. 1986, 7:65-73.
45. Mittal A., Piyathilake C., Hara Y., Katiyar S.K. Exceptionally high protection of photocarcinogenesis by topical application of (-)-epigallocatechin-3-gallate in hydrophilic cream in SKH-1 hairless mouse model: Relationship to inhibition of UVB-induced global DNA hypomethylation. Neoplasia 2003, 5:555-565.
46. Moore L.E., Pfeiffer R.M., Poscablo C., Real F.X., Kogevinas M., Silverman D., García-Closas R., Chanock S., Tardón A., Serra C., et al. Genomic DNA hypomethylation as a biomarker for bladder cancer susceptibility in the Spanish Bladder Cancer Study: A case-control study. Lancet Oncol. 2008, 9:359-366.
47. Murthy S.S., Shen T., De Rienzo A., Lee W.C., Ferriola P.C., Jhanwar S.C., Mossman B.T., Filmus J., Testa J.R. Expression of GPC3, an X-linked recessive overgrowth gene, is silenced in malignant mesothelioma. Oncogene 2000, 19:410-416.
48. Niwa T., Tsukamoto T., Toyoda T., Mori A., Tanaka H., Maekita T., Ichinose M., Tatematsu M., Ushijima T. Inflammatory processes triggered by Helicobacter pylori infection cause aberrant DNA methylation in gastric epithelial cells. Cancer Res. 2010, 70:1430-1440.
49. Oka D., Yamashita S., Tomioka T., Nakanishi Y., Kato H., Kaminishi M., Ushijima T. The presence of aberrant DNA methylation in noncancerous esophageal mucosae in association with smoking history. Cancer 2009, 115:3412-3426.
50. Pufulete M., Al-Ghnaniem R., Khushal A., Appleby P., Harris N., Gout S., Emery P.W., Sanders T.A. Effect of folic acid supplementation on genomic DNA methylation in patients with colorectal adenoma. Gut 2005, 54:648-653.
51. Puri S.K., Si L., Fan C.Y., Hanna E. Aberrant promoter hypermethylation of multiple genes in head and neck squamous cell carcinoma. Am. J. Otolaryngol. 2005, 26:12-17.
52. Russo A.L., Thiagalingam A., Pan H., Califano J., Cheng K.H., Ponte J.F., Chinnappan D., Nemani P., Sidransky D., Thiagalingam S. Differential DNA hypermethylation of critical genes mediates the stage-specific tobacco smoke-induced neoplastic progression of lung cancer. Clin. Cancer Res. 2005, 11:2466-2470.
53. Sarter B., Long T.I., Tsong W.H., Koh W.P., Yu M.C., Laird P.W. Sex differential in methylation patterns of selected genes in Singapore Chinese. Hum. Genet. 2005, 117:402-403.
54. Schnekenburger M., Talaska G., Puga A. Chromium cross-links histone deacetylase 1-DNA methyltransferase 1 complexes to chromatin, inhibiting histone-remodeling marks critical for transcriptional activation. Mol. Cell. Biol. 2007, 27:7089-7101.
55. Takiguchi M., Achanzar W.E., Qu W., Li G., Waalkes M.P. Effects of cadmium on DNA-(Cytosine-5) methyltransferase activity and DNA methylation status during cadmium-induced cellular transformation. Exp. Cell Res. 2003, 286:355-365.
56. Tawa R., Kimura Y., Komura J., Miyamura Y., Kurishita A., Sasaki M.S., Sakurai H., Ono T. Effects of X-ray irradiation on genomic DNA methylation levels in mouse tissues. J. Radiat. Res. 1998, 39:271-278.
57. Vaissière T., Hung R.J., Zaridze D., Moukeria A., Cuenin C., Fasolo V., Ferro G., Paliwal A., Hainaut P., Brennan P., et al. Quantitative analysis of DNA methylation profiles in lung cancer identifies aberrant DNA methylation of specific genes and its association with gender and cancer risk factors. Cancer Res. 2009, 69:243-252.
58. van Engeland M., Weijenberg M.P., Roemen G.M., Brink M., de Bruïne A.P., Goldbohm R.A., van den Brandt P.A., Baylin S.B., de Goeij A.F., Herman J.G. Effects of dietary folate and alcohol intake on promoter methylation in sporadic colorectal cancer: The Netherlands cohort study on diet and cancer. Cancer Res. 2003, 63:3133-3137.
59. Virmani A.K., Muller C., Rathi A., Zoechbauer-Mueller S., Mathis M., Gazdar A.F. Aberrant methylation during cervical carcinogenesis. Clin. Cancer Res. 2001, 7:584-589.
60. Waterland R.A., Jirtle R.L. Transposable elements: Targets for early nutritional effects on epigenetic gene regulation. Mol. Cell. Biol. 2003, 23:5293-5300.
61. Widschwendter M., Apostolidou S., Raum E., Rothenbacher D., Fiegl H., Menon U., Stegmaier C., Jacobs I.J., Brenner H. Epigenotyping in peripheral blood cell DNA and breast cancer risk: A proof of principle study. PLoS ONE 2008, 16:e2656.
62. Wilson V.L., Smith R.A., Ma S., Cutler R.G. Genomic 5-methyldeoxycytidine decreases with age. J. Biol. Chem. 1987, 262:9948-9951.
63. Yoon J.H., Smith L.E., Feng Z., Tang M., Lee C.S., Pfeifer G.P. Methylated CpG dinucleotides are the preferential targets for G-to-T transversion mutations induced by benzo[a]pyrene diol epoxide in mammalian cells: Similarities with the p53 mutation spectrum in smoking-associated lung cancers. Cancer Res. 2001, 61:7110-7117.
64. Yuasa Y., Nagasaki H., Akiyama Y., Hashimoto Y., Takizawa T., Kojima K., Kawano T., Sugihara K., Imai K., Nakachi K. DNA methylation status is inversely correlated with green tea intake and physical activity in gastric cancer patients. Int. J. Cancer 2009, 124:2677-2682.
65. Zhang Y.J., Ahsan H., Chen Y., Lunn R.M., Wang L.Y., Chen S.Y., Lee P.H., Chen C.J., Santella R.M. High frequency of promoter hypermethylation of RASSF1A and p16 and its relationship to aflatoxin B1-DNA adduct levels in human hepatocellular carcinoma. Mol. Carcinog. 2002, 35:85-92.
66. Zhao C.Q., Young M.R., Diwan B.A., Coogan T.P., Waalkes M.P. Association of arsenic-induced malignant transformation with DNA hypomethylation and aberrant gene expression. Proc. Natl. Acad. Sci. USA 1997, 94:10907-10912.